Sly Syndrome · Beta-Glucuronidase Deficiency · GUSB deficiency · MPS 7 · Mucopolysaccharidose Typ VII
Mucopolysaccharidosis Type VII (MPS VII) is an inherited metabolic disorder belonging to a group called lysosomal storage diseases. It occurs when a deficiency in a specific enzyme prevents the body from breaking down complex sugar molecules, leading to a harmful buildup of waste products inside cells. This accumulation causes progressive damage to multiple organ systems, particularly the skeleton and connective tissues.
Symptoms typically become noticeable in early puppyhood and progress rapidly. Owners may observe stunted growth (dwarfism), skeletal deformities, cloudy eyes, and severe difficulty moving.
There is no cure for this condition, and treatment is limited to supportive care to manage pain and maintain comfort. This lifelong palliative care typically costs between 1,000 and 5,000 EUR.
Estimated range of typical treatment cost. Actual cost depends on severity, clinic and region.
More conditions affecting the General / metabolic.